Collectively, the evidence from these studies may not only explain our findings, but also elicit some questions that are in need of further investigation; for instance, whether aspirin use can benefit NPC patients with high COX-2 or PIK3CA expression. This evidence concerns the gene PIK3CA and nasopharyngeal carcinoma.